1. Home
  2. ABCL vs BANF Comparison

ABCL vs BANF Comparison

Compare ABCL & BANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$13.27

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Logo BancFirst Corporation

BANF

BancFirst Corporation

SELL

Current Price

$108.08

Market Cap

3.9B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
ABCL
BANF
Founded
2012
1984
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.9B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
ABCL
BANF
Price
$13.27
$108.08
Analyst Decision
Strong Buy
Hold
Analyst Count
11
3
Target Price
$16.70
★ $124.33
AVG Volume (30 Days)
★ 4.4M
103.9K
Earning Date
11-09-2026
10-16-2026
Dividend Yield
N/A
★ 1.93%
EPS Growth
★ 10.91
10.40
EPS
N/A
★ 3.81
Revenue
★ $75,128,000.00
N/A
Revenue This Year
N/A
$8.37
Revenue Next Year
$7.91
$6.35
P/E Ratio
★ N/A
$27.95
Revenue Growth
★ 160.56
N/A
52 Week Low
$2.75
$101.48
52 Week High
$14.98
$128.87

Technical Indicators

Market Signals
Indicator
ABCL
BANF
Relative Strength Index (RSI) 59.09 46.98
Support Level $10.38 $106.28
Resistance Level N/A $116.82
Average True Range (ATR) 0.77 2.03
MACD 0.05 -0.05
Stochastic Oscillator 58.85 54.10

Price Performance

Historical Comparison
ABCL
BANF

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About BANF BancFirst Corporation

BancFirst Corp is engaged in providing banking services. The company's business unit includes BancFirst metropolitan banks, BancFirst community banks, Pegasus Bank, Worthington, other financial services and executive, operations and support. BancFirst metropolitan banks, BancFirst community banks, Pegasus and Worthington offer traditional banking products such as commercial and retail lending and a full line of deposit accounts. Its Other financial services are specialty product business units including guaranteed small business lending, residential mortgage lending, trust services, securities brokerage, electronic banking, and insurance.

Share on Social Networks: